普瑞眼科
(301239)
| 流通市值：43.91亿 | | | 总市值：46.25亿 |
| 流通股本：1.42亿 | | | 总股本：1.50亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,602,037,256.53 | 820,353,329.11 | 2,797,261,037.47 | 2,200,549,440.39 |
| 营业总成本 | 1,464,529,396.87 | 726,043,058.39 | 2,746,109,913.2 | 2,105,665,391.88 |
| 其他经营收益 | | | | |
| 营业利润 | 138,822,349.8 | 94,247,163.12 | 31,074,382.72 | 91,052,129.69 |
| 利润总额 | 130,763,927.74 | 92,488,069.46 | 12,515,625.08 | 79,830,096.16 |
| 净利润 | 92,350,606.99 | 72,997,490.46 | -53,718,830.86 | 21,588,547.06 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | 29,078.28 | - |
| 综合收益总额 | 92,350,606.99 | 72,997,490.46 | -53,689,752.58 | 21,588,547.06 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,007,025,908.19 | 1,044,311,998.75 | 857,884,517.45 | 873,122,319.94 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,763,834,086.35 | 3,699,425,211.57 | 3,697,889,913.38 | 3,733,834,117.88 |
| 资产总计 | 4,770,859,994.54 | 4,743,737,210.32 | 4,555,774,430.83 | 4,606,956,437.82 |
| 流动负债: | | | | |
| 流动负债合计 | 1,013,989,397.64 | 898,768,576.15 | 866,133,976.92 | 812,811,783.69 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,589,305,629.74 | 1,696,756,783.54 | 1,622,679,017.34 | 1,652,735,472.99 |
| 负债合计 | 2,603,295,027.38 | 2,595,525,359.69 | 2,488,812,994.26 | 2,465,547,256.68 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,130,049,573.64 | 2,112,586,113.46 | 2,041,940,785.1 | 2,124,029,512.57 |
| 股东权益合计 | 2,167,564,967.16 | 2,148,211,850.63 | 2,066,961,436.57 | 2,141,409,181.14 |
| 负债和股东权益合计 | 4,770,859,994.54 | 4,743,737,210.32 | 4,555,774,430.83 | 4,606,956,437.82 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,616,665,046.19 | 825,078,545.4 | 2,842,689,394.07 | 2,236,276,463.31 |
| 经营活动现金流出小计 | 1,283,845,582.09 | 647,590,409.87 | 2,297,831,257.26 | 1,822,151,013.14 |
| 经营活动产生的现金流量净额 | 332,819,464.1 | 177,488,135.53 | 544,858,136.81 | 414,125,450.17 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 91,066,763.61 | 90,961,521.61 | 444,360,875.17 | 330,718,441.8 |
| 投资活动现金流出小计 | 300,983,048.1 | 188,397,441.1 | 891,553,570.34 | 631,067,711.04 |
| 投资活动产生的现金流量净额 | -209,916,284.49 | -97,435,919.49 | -447,192,695.17 | -300,349,269.24 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 133,741,875 | 133,741,875 | 206,179,984 | 80,956,055.72 |
| 筹资活动现金流出小计 | 148,124,078.8 | 66,909,781.29 | 445,584,575.42 | 298,538,469.65 |
| 筹资活动产生的现金流量净额 | -14,382,203.8 | 66,832,093.71 | -239,404,591.42 | -217,582,413.93 |
| 汇率变动对现金及现金等价物的影响 | -145,602.65 | - | 19,625.83 | - |
| 现金及现金等价物净增加额 | 108,375,373.16 | 146,884,309.75 | -141,719,523.95 | -103,806,233 |
| 期末现金及现金等价物余额 | 446,602,452.41 | 485,111,389 | 338,227,079.25 | 376,140,370.2 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 108,375,373.16 | - | -141,719,523.95 | - |